Ivonescimab in the Treatment of Multiple Advanced Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ivonescimab in the Treatment of Multiple Advanced Tumors — Stella

Recruiting

Back to Pheochromocytoma/Paraganglioma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Fudan University Cancer Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing

Sponsor

Fudan University

Enrollment target

~400 participants

Started

November 2024

Primary completion

November 2027

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov